ACARIZAX

This brand name is authorized in Austria, Canada, Finland, France, Hong Kong, Croatia, Ireland, Israel, Netherlands, New Zealand, Poland, Romania, Turkey

Active ingredients

The drug ACARIZAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Dermatophagoides farinae allergen extract UNII PR9U2YPF3Q - DERMATOPHAGOIDES FARINAE

2 Dermatophagoides pteronyssinus allergen extract UNII 57L1Z5378K - DERMATOPHAGOIDES PTERONYSSINUS

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACARIZAX Oral lyophilisate	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V01AA03	House dust	V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02463644
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 186748, 555047
Country: FR	Base de données publique des médicaments	Identifier(s): 67813445
Country: HK	Department of Health Drug Office	Identifier(s): 65924
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8808
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 205400
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18800
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100330160
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67212001, W67212002, W67212003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681078093945, 8681078093952, 8681078093969